Table 6.
All | Survived | Dead | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p value | OR | 95% CI | p value | ||||
N | 96 | 60 (62%) | 36 (38%) | ||||||
Age | 69 (40–78) | 65 (40–78) | 72 (47–78) | 0.9919 | 0.9593–1.0257 | 0.636 | 1.0092 | 0.9729–1.0469 | 0.623 |
Saps II | 40 (14–82) | 37 (14–82) | 60 (20–82) | 0.9698 | 0.9498–0.9902 | 0.003 | 0.9681 | 0.9469–0.9897 | 0.004 |
Male | 66 (69%) | 46 (77%) | 20 (55%) | 0.3804 | 0.1564–0.9253 | 0.033 | 0.2713 | 0.0919–0.8013 | 0.018 |
Female | 30 (31%) | 14 (23%) | 16 (45%) | ||||||
ACS | 48 (50%) | 24 (40%) | 24 (67%) | 3.0000 | 1.2641–7.1198 | 0.012 | 2.1823 | 0.7887–6.0383 | 0.013 |
Other reasons | 48 (50%) | 36 (60%) | 12 (33%) | ||||||
Cv disease | 34 (35%) | 14 (23%) | 20 (55%) | 4.1071 | 1.6886–9.9900 | 0.001 | 6.6032 | 2.2207–19.6343 | 0.0007 |
Other disease | 62 (65%) | 46 (77%) | 16 (45%) | ||||||
VAWCM | 69 (72%) | 50 (83%) | 19 (53%) | 0.2235 | 0.0871–0.5739 | 0.001 | 0.1498 | 0.0486–0.4615 | 0.0009 |
VAWC | 27 (28%) | 10 (17%) | 17 (47%) |